Author: Hudson Bellamy - Page 4

Language Access for Medication Counseling: What You Need to Know About Interpreter Rights
Dec 8 2025 Hudson Bellamy

Language Access for Medication Counseling: What You Need to Know About Interpreter Rights

Language access laws now require pharmacies to provide professional interpreters for medication counseling. Learn your rights, what pharmacies must offer, and how this saves lives by preventing dangerous medication errors.

Detail
When to Avoid a Medication Family After a Severe Drug Reaction
Dec 7 2025 Hudson Bellamy

When to Avoid a Medication Family After a Severe Drug Reaction

After a severe drug reaction, you may need to avoid an entire medication family-but not always. Learn when cross-reactivity is real, when it’s a myth, and how to get tested to avoid unnecessary restrictions.

Detail
Batch Variability and Bioequivalence: What Acceptable Limits Really Mean for Generic Drugs
Dec 6 2025 Hudson Bellamy

Batch Variability and Bioequivalence: What Acceptable Limits Really Mean for Generic Drugs

Batch variability can make or break generic drug safety. Learn how regulators are changing bioequivalence standards to ensure consistent, reliable generic medications-without compromising access or cost.

Detail
How to Check for Drug Interactions at Home Safely
Dec 5 2025 Hudson Bellamy

How to Check for Drug Interactions at Home Safely

Learn how to safely check for drug interactions at home using free tools, what to look for, and when to call your pharmacist. Avoid dangerous combos between prescriptions, OTC meds, and supplements.

Detail
Renal Dosing for Metformin and SGLT2 Inhibitors: When to Adjust in 2025
Dec 3 2025 Hudson Bellamy

Renal Dosing for Metformin and SGLT2 Inhibitors: When to Adjust in 2025

Updated 2025 guidelines on when to adjust metformin and SGLT2 inhibitor doses in kidney disease. Know the eGFR thresholds, what to do when levels drop, and how to fight insurance denials.

Detail
FDA Authorization of Generics: Legal Basis and Approval Process
Dec 2 2025 Hudson Bellamy

FDA Authorization of Generics: Legal Basis and Approval Process

The FDA approves generic drugs through the Hatch-Waxman Act's ANDA pathway, ensuring they match brand-name drugs in safety, strength, and effectiveness. Over 90% of U.S. prescriptions are for generics, saving billions annually.

Detail
FDA Bioequivalence Standards for NTI Drugs: What You Need to Know
Dec 1 2025 Hudson Bellamy

FDA Bioequivalence Standards for NTI Drugs: What You Need to Know

The FDA enforces stricter bioequivalence standards for narrow therapeutic index (NTI) drugs like warfarin, phenytoin, and digoxin. Learn how 90-111% limits, replicate studies, and tighter quality controls ensure patient safety with generic versions.

Detail
Generic Copays vs Brand Copays: Average 2024 Costs Explained
Dec 1 2025 Hudson Bellamy

Generic Copays vs Brand Copays: Average 2024 Costs Explained

Learn the real costs of generic vs brand-name drug copays in 2024. See how Medicare and private plans charge differently, what’s changing in 2025, and how to save money on prescriptions.

Detail
Fatigue in Autoimmune Disease: What Causes It and How to Manage It
Dec 1 2025 Hudson Bellamy

Fatigue in Autoimmune Disease: What Causes It and How to Manage It

Fatigue in autoimmune disease is a debilitating, persistent exhaustion caused by inflammation, not just lack of sleep. Learn the real causes, how it's measured, and proven strategies to manage it - from pacing to targeted supplements.

Detail
Joint Pain and Your Immune System: How Inflammation Is the Hidden Cause
Dec 1 2025 Hudson Bellamy

Joint Pain and Your Immune System: How Inflammation Is the Hidden Cause

Chronic joint pain often stems from hidden inflammation driven by your immune system-not aging or overuse. Learn how to identify inflammatory joint pain, what causes it, and what actually works to stop the damage before it’s permanent.

Detail